A non-metal, polymeric tubular device for delivering a therapeutic fluid to a treatment site within a patient. The non-metal, polymeric tubular device can be fabricated using suitable high strength polymers and in some versions can be reinforced through the inclusion of reinforcement materials or br
A non-metal, polymeric tubular device for delivering a therapeutic fluid to a treatment site within a patient. The non-metal, polymeric tubular device can be fabricated using suitable high strength polymers and in some versions can be reinforced through the inclusion of reinforcement materials or braiding. The non-metal, polymeric tubular device can be fabricated so as to have a burst strength exceeding at least about 2,000 psi. The non-metal, polymeric tubular device can be fabricated so as to have distention properties, wherein an orifice or jet port located at a distal end of the polymeric tubular device retains its shape and/or size without suffering swelling that can have a detrimental impact on a fluid jet used to deliver the therapeutic fluid at the treatment site.
대표청구항▼
1. A needleless non-metal, polymeric tubular injection device for delivering a therapeutic fluid to a treatment location within a patient's body, the device comprising an applicator body defining a lumen and a sidewall, the applicator body including a distal end and a proximal connection end, wherei
1. A needleless non-metal, polymeric tubular injection device for delivering a therapeutic fluid to a treatment location within a patient's body, the device comprising an applicator body defining a lumen and a sidewall, the applicator body including a distal end and a proximal connection end, wherein an administration orifice is positioned through the sidewall proximate the distal end; wherein the applicator body comprises a polymer selected from a group consisting of: a polyimide polymer, a polyetherimide polymer, and a polyether ether ketone; wherein the applicator body exhibits a burst strength of at least 2,000 pounds per square inch; in combination with a cystoscope; wherein the applicator body extends distally from a distal end of the cystoscope such that the administration orifice may be positioned with unobstructed access to tissue of a urogenital tract to inject therapeutic fluid into the tissue of the urogenital tract for the injected therapeutic fluid to remain in the tissue in the patient's body. 2. The non-metal, polymeric tubular device of claim 1 wherein the applicator body is fabricated of a single polymer selected from the group consisting of polyimide polymer, polyetherimide polymer, and polyether ether ketone. 3. The non-metal, polymeric tubular device of claim 1 wherein the applicator body comprises an extruded applicator body having a length of about 18 inches to about 72 inches and a substantially uniform diameter along the tube length. 4. The non-metal, polymeric tubular device of claim 1 wherein the applicator body is formed of a non-reinforced polyether ether ketone polymer. 5. The non-metal, polymeric tubular device of claim 1 wherein the applicator body is formed of reinforced polyether ether ketone polymer. 6. The non-metal, polymeric tubular device according to claim 1 wherein the distal end, the applicator body, and the administration orifice are configured to eject fluid from the administration orifice laterally to transurethrally penetrate and treat a prostate gland. 7. The non-metal, polymeric tubular device according to claim 1 comprising a fiber optic scope adapted to view the injection orifice relative to a treatment location. 8. A needleless injection system comprising the non-metal, polymeric tubular device of claim 1 and further comprising an injector. 9. The needleless fluid delivery system of claim 8 wherein the injector comprises an automated injector having a user interface and a connector member attachable to the proximal connection end. 10. The needleless fluid delivery system according to claim 9 wherein the proximal connection end engages the automated injector independently of the cystoscope, and a length of the applicator lumen extends between the automated injector and the cystoscope. 11. The needleless fluid delivery system according to claim 10 wherein the applicator body is extruded polymer and has a length of about 18 inches to about 72 inches and a substantially uniform diameter along the length. 12. The needleless fluid delivery system of claim 8 wherein the applicator body is fabricated of a single polymer selected from the group consisting of polyimide polymer, polyetherimide polymer, and polyether ether ketone. 13. The needleless fluid delivery system of claim 8 wherein the distal end, applicator body, and administration orifice are configured to eject fluid from the administration orifice laterally to transurethrally penetrate and treat a prostate gland. 14. The needleless fluid delivery system according to claim 8 wherein the tissue is bladder tissue. 15. The needleless fluid delivery system according to claim 8 comprising a fiber optic scope adapted to view the injection orifice relative to a treatment location. 16. A method of injecting a therapeutic fluid into tissue of a urogenital tract of a patient, the method comprising providing a device according to claim 1,passing the distal end within a urethra of the patient,positioning the distal end at a treatment location such that the administration orifice is positioned to inject therapeutic fluid into the tissue, andinjecting therapeutic fluid into the tissue, with the therapeutic fluid remaining in the tissue in the patient's body. 17. The method according to claim 16 wherein the tissue is bladder tissue.
연구과제 타임라인
LOADING...
LOADING...
LOADING...
LOADING...
LOADING...
이 특허에 인용된 특허 (60)
Peters Michael J. (2196 Wycliffe West Bloomfield MI 48323), Bladder catheter.
Glines, Robert C.; Weller, Gary B., Device and methods for the delivery and injection of therapeutic and diagnostic agents to a target site within a body.
Conlan A. Alan ; Kazakevich Yuri E. ; Ek Steven W. ; Mihalca Gheorghe, Intravascular catheter and method of controlling hemorrhage during minimally invasive surgery.
Ferguson Robert D. G. (Memphis TN) Tartaglino Sandra G. (Canton MA), Method of delivering a therapeutic agent or diagnostic device using a micro occlusion balloon catheter.
Makower, Joshua; Lamson, Theodore C.; Flaherty, J. Christopher; Reggie, John A.; Chang, John Y.; Catanese, III, Joseph; Tholfsen, David R., Methods and apparatus for acute or chronic delivery of substances or apparatus to extravascular treatment sites.
Corday Eliot (810 N. Roxbury Beverly Hills CA 90210) Meerbaum Samuel (5741 El Canon Woodland Hills CA 91364), Retrograde delivery of pharmacologic and diagnostic agents via venous circulation.
Belson, Amir; Frey, Paul DeWitt; Mcelhaney, Christine Wei Hsien; Milroy, James Craig; Ohline, Robert Matthew; Tartaglia, Joseph M., Steerable segmented endoscope and method of insertion.
Lampropoulos Fred P. (Salt Lake City UT) Taylor Steven R. (Salt Lake City UT) Salisbury Jeffrey D. (Logan UT) Foote Jerrold L. (Salt Lake City UT), System and method for monitoring, displaying and recording balloon catheter condition interval data.
Jang G. David (636 Golden West Dr. Redlands CA 92373), Tandem independently inflatable/deflatable multiple diameter balloon angioplasty catheter systems and method of use.
Clark David W. ; Clark Souise S. ; Chornenky Victor I. ; Forman Michael R. ; Lee Jeffrey A., Thrombolytic filtration and drug delivery catheter with a self-expanding portion.
Edwards Stuart D. (Los Altos CA) Lax Ronald G. (Grass Valley CA) Sharkey Hugh R. (Redwood City CA), Transurethral needle delivery device with cystoscope and method for treatment of urinary incontinence.
Reif Thomas H. (5213 Greencroft Dr. Dayton OH 45426) Warnken Louis E. (197 Lindall Dr. Germantown OH 45327) Snyder Roy A. (8705 Cheshire Ct. Jessup MD 20794), Urinary catheter package.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.